1222174-92-6

Basic information

• Product Name: Methyl 5-bromo-1-methyl-1H-pyrazole-3-carboxylate
• Synonyms: Methyl 5-bromo-1-methyl-1H-pyrazole-3-carboxylate
• CAS NO: 1222174-92-6
• Molecular Formula: C₆H₇BrN₂O₂
• Molecular Weight: 219.03598
• Mol File: 1222174-92-6.mol
• Article Data: 8

Chemical Properties

• Boiling Point: 280.4±20.0 °C(Predicted)
• Appearance: /
• Density: 1.67±0.1 g/cm3(Predicted)
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• PKA: -1.41±0.10(Predicted)
• CAS DataBase Reference: Methyl 5-bromo-1-methyl-1H-pyrazole-3-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: Methyl 5-bromo-1-methyl-1H-pyrazole-3-carboxylate(1222174-92-6)
• EPA Substance Registry System: Methyl 5-bromo-1-methyl-1H-pyrazole-3-carboxylate(1222174-92-6)

Safety Data

• Hazardous Substances Data: 1222174-92-6(Hazardous Substances Data)

Usage

General Description

Methyl 5-bromo-1-methyl-1H-pyrazole-3-carboxylate is a chemical compound containing pyrazole, a key component used in a variety of pharmaceuticals. Pyrazole derived compounds are noted for their vast biological activities. Methyl 5-bromo-1-methyl-1H-pyrazole-3-carboxylate, as the name suggests, contains a methyl group and a bromine atom attached to the pyrazole ring. The presence of the carboxylate group suggests its role as a potential intermediate in synthesis or a chemical probe. However, comprehensive studies regarding its specific uses or properties are limited. Its molecular formula is C6H6BrNO2. Like most chemicals, this substance should be handled using appropriate safety precautions.

Upstream product

• 762-42-5 dimethyl acetylenedicarboxylate 
• 51985-95-6 methyl 5-hydroxy-1-methyl-1H-pyrazole-3-carboxylate 

Downstream Products

• 1222174-93-7 5-bromo-1-methyl-1H-pyrazole-3-carboxylic acid 
• 203792-51-2 methyl 5-cyano-1-methyl-1H-pyrazole-3-carboxylate 
• 203792-50-1 methyl 5-carbamoyl-1-methyl-1H-pyrazole-3-carboxylate 
• 1617523-10-0 5-bromo-N-(2,6-difluorophenyl)-1-methyl-1H-pyrazole-3-carboxamide 
• 1617523-52-0 C₁₃H₁₁F₃N₂O₂ 
• 1456071-47-8 C₁₄H₁₆N₂O₄ 
• 1617522-52-7 5-(2,5-dimethoxyphenyl)-1-methyl-N-(3-methyl-pyridin-4-yl)-1H-pyrazole-3-carboxylic acid amide 
• 1617522-35-6 5-(2,5-dimethoxyphenyl)-N-(2-fluoro-4-methylsulfonyl-phenyl)-1-methyl-1H-pyrazole-3-carboxylic acid amide 
• 1177228-47-5 C₁₃H₁₄N₂O₄ 
• 1617521-89-7 N-(2,4-difluoro-phenyl)-5-(2,5-dimethoxyphenyl)-1-methyl-1H-pyrazole-3-carboxylic acid amide 
• 1617522-72-1 N-(2,6-difluoro-4-methoxy-phenyl)-5-(2,5-dimethoxyphenyl)-1-methyl-1H-pyrazole-3-carboxylic acid amide 
• 1617522-66-3 5-(2,5-dimethoxyphenyl)-1-methyl-N-(o-tolyl)-1H-pyrazole-3-carboxylic acid amide 
• 1349698-77-6 4-[({5-[2-ethoxymethyl-1-(2-(trimethylsilanyl)ethoxymethyl)-1H-indol-5-yl]-1-methyl-1H-pyrazole-3-carbonyl}amino)methyl]benzoic acid 
• 1349698-71-0 C₁₄H₁₄BrN₃O₃ 

Relevant articles and documents

PYRAZOLYL-BASED CARBOXAMIDES USEFUL AS CALCIUM RELEASE ACTIVATED CALCIUM CHANNEL (ICRAC) INHIBITORS

The invention relates to pyrazolyl-based carboxamide compounds useful as ICRAC inhibitors, to pharmaceutical compositions containing these compounds and to these compounds for the use in the treatment and/or prophylaxis of diseases and/or disorders, in pa

PYRIDINYL-SUBSTITUTED PYRAZOLYL CARBOXAMIDES

The invention relates to pyrazolyl-based carboxamide compounds useful as ICRAC inhibitors, to pharmaceutical compositions containing these compounds and to methods of using these compounds for the treatment and/or prophylaxis of diseases and/or disorders, in particular inflammatory diseases and/or inflammatory disorders.

PYRAZOLYL-BASED CARBOXAMIDES II AS CRAC CHANNEL INHIBITORS

The invention relates to pyrazolyl-based carboxamide compounds of formula (I) useful as ICRAC inhibitors, to pharmaceutical compositions containing these compounds and to these compounds for the use in the treatment and/or prophylaxis of diseases and/or disorders, in particular inflammatory diseases and/or inflammatory disorders.